Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 8Genitourinary 5Other hematologic neoplasm 2Lymphoid 2Gynecologic 2Sarcoma 1Myeloid 1CNS 1

Conditions

Uterine Cervical Neoplasms 2Ovarian Neoplasms 2Osteoporosis 2With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer 1Uterine Cervical Dysplasia 1Precancerous Conditions 1Myelodysplastic Syndromes 1Lymphoma 1Leukemia 1Hereditary Breast and Ovarian Cancer Syndrome 1

Interventions

Zoledronic Acid 2Linseed Oil 1Cholecalciferol 1Calcium Gluconate 1Calcium Citrate 1Calcium Carbonate 1Calcium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Osteoporosis × Zoledronic Acid × Gynecologic × Clear all
NCT00305695 2020-03-24

Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries

GOG Foundation

Phase 2 Completed
160 enrolled 10 charts
BreastGynecologic

Osteoporosis, Ovarian Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

NCT00321932 2017-03-09

Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant

University of Minnesota

Phase 2 Completed
61 enrolled 16 charts
GynecologicLymphoidMyeloidOther hematologic neoplasm

Leukemia, Lymphoma, Myelodysplastic Syndromes, Osteoporosis, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡